Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98
Author(s)
Doern, GV
Brueggemann, AB
Huynh, H
Wingert, E
Rhomberg, P
Type
Journal Article
Abstract
From November 1997 to April 1998, 1,601 clinical isolates of
Streptococcus
pneumoniae
were obtained from 34 U.S. medical centers. The overall rate of strains
showing resistance to penicillin was 29.5%, with 17.4% having intermediate resistance.
Multidrug resistance, defined as lack of susceptibility to penicillin and at least two other
non-ß-lactam classes of antimicrobial drugs, was observed in 16.0% of isolates.
Resistance to all 10 ß-lactam drugs examined in this study was directly related to the
level of penicillin resistance. Penicillin resistance rates were highest in isolates from
middle ear fluid and sinus aspirates of children <5 years of age and from patients in
ambulatory-care settings. Twenty-four of the 34 medical centers in this study had
participated in a similar study 3 years before. In 19 of these 24 centers, penicillin
resistance rates increased 2.9% to 39.2%. Similar increases were observed with rates
of resistance to other antimicrobial drugs.
Streptococcus
pneumoniae
were obtained from 34 U.S. medical centers. The overall rate of strains
showing resistance to penicillin was 29.5%, with 17.4% having intermediate resistance.
Multidrug resistance, defined as lack of susceptibility to penicillin and at least two other
non-ß-lactam classes of antimicrobial drugs, was observed in 16.0% of isolates.
Resistance to all 10 ß-lactam drugs examined in this study was directly related to the
level of penicillin resistance. Penicillin resistance rates were highest in isolates from
middle ear fluid and sinus aspirates of children <5 years of age and from patients in
ambulatory-care settings. Twenty-four of the 34 medical centers in this study had
participated in a similar study 3 years before. In 19 of these 24 centers, penicillin
resistance rates increased 2.9% to 39.2%. Similar increases were observed with rates
of resistance to other antimicrobial drugs.
Date Issued
1999-11-01
Date Acceptance
1999-11-01
Citation
EMERGING INFECTIOUS DISEASES, 1999, 5 (6), pp.757-765
ISSN
1080-6040
Publisher
CENTER DISEASE CONTROL
Start Page
757
End Page
765
Journal / Book Title
EMERGING INFECTIOUS DISEASES
Volume
5
Issue
6
Copyright Statement
© 1999 The Author(s). This article is open access under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000084408100003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
PENICILLIN-BINDING PROTEIN-2X
SURVEILLANCE
PREVALENCE
Child, Preschool
Drug Resistance, Multiple
Humans
Microbial Sensitivity Tests
Penicillin Resistance
Streptococcus pneumoniae
United States
1108 Medical Microbiology
1117 Public Health And Health Services
1103 Clinical Sciences
Microbiology
Publication Status
Published